Tandem Diabetes Care (TNDM) Stock News
$TNDM · NASDAQ · HEALTHCARE · 1 stories in 30 daysBORSA has published 1 story on Tandem Diabetes Care (TNDM) in the past 30 days. BORSA’s news read on TNDM is bullish at 71/100, based on 1 company event over the past 7 days. TNDM last closed at $18.77 on Nov 11, down 1.47% over five sessions and up 12.73% over the past month. Tandem Diabetes Care last reported quarterly results on Nov 5, 2026, for the quarter ended Sep 30, 2026.
The wire on $TNDM
newest first · updated · direct subject stories onlyHealth Canada approved Tandem's t:slim X2 pump for use with Abbott's FreeStyle Libre 3 Plus sensor and for type 2 diabetes and pregnancy in type 1 diabetes. Availability expected Q2 2027.
bullish 70 · impact 60The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
Tandem Diabetes Care (TNDM) stock: common questions
What is the latest Tandem Diabetes Care stock news?
The highest-impact TNDM story BORSA published in the past 30 days:
· Tandem Diabetes Care receives Health Canada approvals for t:slim X2 pump